pET-5a
rbsBgl II Xba I
T7 promoter primer #69348-3
T7 promoter
pBR322 EcoR I clockwise primer
ori (2308)
A
p
(3
06
9-
39
26
)
BamH I(4)
Nhe I(37)
Nde I(44) Xba
J. Clin.
Microbiol. 26, 875 (1988); E. Leifson, Am. J. Hyg. 24, 423 (1936)
2. A. Klett, Zeitsch. für Hyg. und Infekt. 33, 137 (1900)
3. F. Guth, Zbl. Bakt. I. Orig. 77, 487 (1916)
4. E. Leifson
mikrobiologischen Nach-
weis von Hemmstoffen in tierischen Produkten. - Fleischwirtsch., 52; 485-
487 (1972).
Ordering Information
Product Ordering No. Pack size
Test Agar for the Residue
Test acc
demonstration of fetal eryth ro cytes in
the presence of adult blood cells. Am J Clin Pathol 40:487, 1963
8. Barr JK, Shafer JA: Preparation and storage of control slides for fetal hemoglobin
determination
Data Sheet
2. Rucki, R., Anal. Profiles of Drug Subs., K. Florey, ed. Academic Press, NY, 6, 487, 1977.
3. Frank, M.J., et al., J. Pharm. Sci., 65, 44, 1976.
4. Bult, A., et al., Anal. Profiles of Drug
al., Nature Medicine (2005) 11:538-544.
67) Peretto, P., et al., J. Comparative Neurology (2005) 487:407-427.
68) Scheffler, B., et al., PNAS (2005) 102:9353-9358.
69) Yang, P., et al., J. Comparative
Series),
1927. 60(7): p. 1658-1663.
26. Helfand, W.H. and D.L. Cowen, Evolution of Pharmaceutical Oral
Dosage Forms. Pharmacy in History, 1983. 25(1): p. 3-18.
27. Sixty-first meeting of the Joint
step by treatment with reagent K.
Method 8: Methanolic ammonia cleavage to give peptide amides
[3, 26]
1. Place dry resin in a flask and add 95% aqueous TFA (20 ml/g). Stopper the flask and leave to
. Sci., 6, 26
31. Y. Feng & K. Burgess (1999) Chem. Eur. J., 5, 3261.
32. S. Matysiak, et al. (1998) Tetrahedron Lett., 39, 1733.
33. F. Albericio, et al (1993) Tetrahedron Lett., 34, 1549.
3 S. A. Kates
bands combine to a single band
of ~50 kDa after treatment with endoglycosidase F.
Anti-BACE (487-501), Human (Rabbit) 195102 100 µl Recognizes bands of ~65 and ~75 kDa in CHO cells
IB transfected
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
chicken 1897�1 1 ml €97
Anti-BACE (26-45) Rabbit pAb IB, IP human 195100 100 µl €262
Anti-BACE (46-65) Rabbit pAb IB, IP human 195101 100 µl €262
Anti-BACE (487-501) Rabbit pAb IB, IP hamster, human
y
484 Myosin VI M0691 M y y y
485 Myosin VI M5187 P n/d n/d y
486 NBS1 (Nibrin) N9287 M y n/d n/d
487 NBS1 (Nibrin) N3037 P y n/d n/d
488 NBS1 (Nibrin) N3162 P y n/d y
489 Nck-2 N2911 M y